OrthoPediatrics caters to neglected pediatric market — 6 observations

Using its unique resources, Warsaw, Ind.-based OrthoPediatrics continues to grow the pediatric orthopedic devices market, according to Today’s Medical Developments.

Advertisement

Here are six things to know:

 

1. OrthoPediatrics has grown at a 32 percent rate over the past five years, with 20 percent of its sales coming from outside the U.S.

 

2. The company has received clearance for 18 surgical systems for trauma, long bone deformity and correction, scoliosis and sports medicine.

 

3. Children benefit more from pediatric devices and implants as opposed to adult devices.

 

4. Early on in its existence, OrthoPediatrics obtained exclusive rights to the Cleveland Museum of Natural History’s Hamann-Todd Human Osteological Collection, which has the world’s largest documented collection of modern human skeletal remains.

 

5. Having access to this resource allows the company to understand the curvature of children’s bones, which can be30 percent more curved than adult bones.

 

6. OrthoPediatrics makes its devices with stainless steel instead of titanium so that they don’t stick to bones and are easier to remove without violating vascular structure as children grow.

 

More articles on devices:
Dreal device enhances decompression procedure and protects spinal structures — 5 insights

ConforMIS’ technology to design 3D-printed knees

NuVasive, Stryker, Mazor Robotics & more: 14 device company key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.